BioPharma Credit PLC (BPCR) — Free Cash Flow Generation Index
Latest as of June 2025:
1.00x
BioPharma Credit PLC (BPCR) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $33.76 Million represents 1% of operating cash flow ($33.76 Million). Read total liabilities of BioPharma Credit PLC for a breakdown of total debt and financial obligations.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$33.76 Million
USD
Operating Cash Flow
$33.76 Million
USD
Capital Expenditures
$0.00
USD
BioPharma Credit PLC Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for BioPharma Credit PLC across 8 annual periods.
Annual Free Cash Flow Generation for BioPharma Credit PLC (2017–2024)
Year-by-year Free Cash Flow Generation Index for BioPharma Credit PLC. For the full company profile including market capitalisation, see market value of BioPharma Credit PLC.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.00x | $111.91 Million | $111.91 Million | $0.00 | ▲ +0.0% |
| 2023 | 1.00x | $123.18 Million | $123.18 Million | $0.00 | ▲ +0.0% |
| 2022 | 1.00x | $184.28 Million | $184.28 Million | $0.00 | ▲ +0.0% |
| 2021 | 1.00x | $96.44 Million | $96.44 Million | $0.00 | ▲ +0.0% |
| 2020 | 1.00x | $58.07 Million | $58.07 Million | $0.00 | ▲ +0.0% |
| 2019 | 1.00x | $131.52 Million | $131.52 Million | $0.00 | ▲ +0.0% |
| 2018 | 1.00x | $67.14 Million | $67.14 Million | $0.00 | ▲ +0.0% |
| 2017 | 1.00x | $23.07 Million | $23.07 Million | $0.00 | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).